Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits.
Implication of matrix metalloproteinases in regulating neuronal disorder.
Application of next-generation sequencing technologies in Neurology.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).]
Chronic cerebrospinal venous insufficiency in multiple sclerosis: A sonographer-blinded case-control study.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
[Diagnosis and monitoring of multiple sclerosis : The value of optical coherence tomography.]
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.
Late-onset multiple sclerosis in South-East wales.
New clinical insights into combined central and peripheral demyelination (CCPD).
Molecular basis of axonal dysfunction and traffic impairments in CMT.
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
Pages
« first
‹ previous
…
555
556
557
558
559
560
561
562
563
…
next ›
last »